Analysts Set Quipt Home Medical Corp. (NASDAQ:QIPT) Target Price at $6.25

Quipt Home Medical Corp. (NASDAQ:QIPT - Get Free Report) has been given an average rating of "Buy" by the six analysts that are covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, three have issued a buy rating and two have assigned a strong buy rating to the company. The average 12-month price objective among brokers that have covered the stock in the last year is $6.25.

Several analysts recently commented on the stock. Canaccord Genuity Group cut their price objective on shares of Quipt Home Medical from $8.00 to $6.00 and set a "buy" rating on the stock in a research report on Friday, August 16th. Benchmark reduced their price target on shares of Quipt Home Medical from $9.00 to $7.00 and set a "buy" rating for the company in a research report on Wednesday, August 21st.

Institutional Investors Weigh In On Quipt Home Medical

Large investors have recently added to or reduced their stakes in the stock. Forager Capital Management LLC increased its holdings in Quipt Home Medical by 77.7% in the 3rd quarter. Forager Capital Management LLC now owns 4,192,562 shares of the company's stock worth $12,200,000 after acquiring an additional 1,833,590 shares in the last quarter. Royce & Associates LP raised its position in shares of Quipt Home Medical by 15.8% during the 3rd quarter. Royce & Associates LP now owns 1,768,789 shares of the company's stock valued at $5,165,000 after purchasing an additional 240,980 shares during the period. Boston Partners lifted its stake in shares of Quipt Home Medical by 12.8% during the 1st quarter. Boston Partners now owns 742,006 shares of the company's stock valued at $3,243,000 after buying an additional 84,182 shares in the last quarter. State Street Corp boosted its holdings in Quipt Home Medical by 1.0% in the 3rd quarter. State Street Corp now owns 621,388 shares of the company's stock worth $1,814,000 after buying an additional 6,317 shares during the period. Finally, Russell Investments Group Ltd. raised its holdings in Quipt Home Medical by 2.4% during the first quarter. Russell Investments Group Ltd. now owns 511,348 shares of the company's stock valued at $2,235,000 after acquiring an additional 12,070 shares during the period. Institutional investors own 42.85% of the company's stock.

Quipt Home Medical Stock Down 1.2 %

Shares of Quipt Home Medical stock traded down $0.03 during midday trading on Wednesday, hitting $2.42. The company had a trading volume of 174,381 shares, compared to its average volume of 189,481. The company has a 50 day moving average of $2.75 and a 200 day moving average of $3.08. The stock has a market capitalization of $104.28 million, a P/E ratio of -22.00 and a beta of 0.62. Quipt Home Medical has a 52-week low of $2.35 and a 52-week high of $5.29. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.77 and a current ratio of 1.11.

About Quipt Home Medical

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.